Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo's IDE Application For Heart Preservation Technology Approved By FDA

May 15 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * XVIVO'S IDE APPLICATION FOR ITS INNOVATIVE HEART PRESERVATION TECHNOLOGY HAS BEEN APPROVED
BY
THE US FDA
    * TRIAL WILL ENROLL 141 PATIENTS ACROSS 15 LEADING TRANSPLANT CENTERS IN US

Source text for Eikon:  ID:nMFN5P1YZq 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xvivo Perfusion AB

See all news